The CORALreef Lipids trial in patients with elevated cholesterol (hypercholesterolaemia) at risk of atherosclerotic ...

The once-weekly subcutaneous autoinjector picked up an FDA approval late last week that clears the way for it to be an ...

Novartis is paying $160 million upfront to activate an R&D alliance with China's Argo Biopharma covering multiple ...

Weinreich has been named global head of R&D and chief medical officer for Merck's healthcare unit, joining the company from ...

Stoakes has spent 30+ years at the intersection of tech, science, and design, operating with the focal goal of transforming ...

The 7th Gene Therapy Analytical Development Summit is your opportunity to stay ahead of regulatory expectations, benchmark ...

Dr Paul Offit, a vaccine scientist at Children's Hospital of Philadelphia and a member of the FDA's Vaccines and Related ...

Unlocking Safe & Efficacious CNS Gene Therapy: Accurately Targeting CNS Disorders with Next-Gen Delivery Methods & Regulatory ...

Fierce Pharma Week 2025, 8 th to 11th September 2025 in Philadelphia marks a historic shift in pharmaceutical industry events. For the first time, Questex is bringing together marketing, ...

The team from the Universities of Bath and Bristol – led by Bath cognitive neuroscientist Dr George Stothart – have carried ...

The results of the 6,105-patient VICTOR study showed that Verquvo (vericiguat) was unable to meet its objective of reducing ...

No fewer than nine former directors of the CDC, serving under both Democratic and Republican presidents, have said every ...